<DOC>
	<DOCNO>NCT02100657</DOCNO>
	<brief_summary>Study Plitidepsin ( Aplidin® ) determine recommend dose ( RD ) plitidepsin Combination Bortezomib Dexamethasone Patients Relapsed and/or Refractory Multiple Myeloma .</brief_summary>
	<brief_title>Study Plitidepsin ( Aplidin® ) Combination With Bortezomib Dexamethasone Patients With Multiple Myeloma</brief_title>
	<detailed_description>Phase I Multicenter , Open-label , Dose-escalating Clinical Pharmacokinetic Trial Plitidepsin ( Aplidin® ) determine recommend dose ( RD ) plitidepsin combination bortezomib dexamethasone patient relapse and/or refractory multiple myeloma ( MM ) , determine efficacy combination plitidepsin/bortezomib/dexamethasone , evaluate safety tolerability combination patient relapse and/or refractory MM study pharmacokinetics ( PK ) pharmacodynamics ( PDy ) plitidepsin combination bortezomib dexamethasone .</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>Bortezomib</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Age ≥ 18 year . Prior autologous transplantation ( HSCT ) patient allow . Patients must receive least one previous treatment line induction , chemotherapy , chemotherapy transplantation previous treatment bortezomib another proteasome drug Previous treatment plitidepsin . Active metastatic primary malignancy MM . Serious concomitant systemic disorder History hypersensitivity reaction bortezomib , polyoxyl 35 castor oil mannitol Neuropathy Pregnant and/or lactate woman HIV infection Active hepatitis B C virus infection . Treatment Investigational Medicinal Product ( IMP ) 30 day inclusion study Plasma cell leukemia time study entry Contraindication use steroid</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>multiple myeloma</keyword>
	<keyword>plitidepsin</keyword>
	<keyword>APLIDIN</keyword>
</DOC>